Rely+On" Virkon" Broad Spectrum Disinfectant
Rely+On" Virkon" broad spectrum disinfectant is ideal for the cleaning and disinfecting of hard non-porous surfaces. It is not only proven effective against common disease-causing pathogens that affect human health such as, Norovirus, Influenza virus, Salmonella enterica and Campylobacter jejuni, but also it is efficacious against prevalent hospital and food-borne pathogens such as MRSA, VRE and RSV, Hepatitis A Virus and E. coli 0157:H7.
MRSA: Methicillin-Resistant Staphylococcus aureus VRE: Vancomycin-Resistant Enterococcus faecalis RSV: Respiratory Syncytial Virus
INACTIVATES CORONAVIRUS QUICKLY
The coronavirus continues to spread. Authorities around the world are therefore tightening measures to stop the further spread of the lung disease. With no vaccine available, disinfection is of the utmost importance. The high level disinfectant Rely+On Virkon from specialty chemicals company LANXESS is effective against the corona virus. The product is used for hard surface and equipment disinfection. Anneliese Bischof, Head of the Disinfectants Business at LANXESS: Following the outbreak of the coronavirus, we are seeing increased demand for Rely+On Virkon in China and other countries around the globe. We are therefore currently working intensively to optimally align our production and logistics capacities to deliver additional product quantity to this region as quickly as possible.
Independent tests have proven that Rely+On Virkon inactivates a closely related surrogate of the currently spreading coronavirus strain. From these tests it can be concluded that Rely+On Virkon is also effective against 2019-nCoV, Bischof said.In independent tests Rely+On Virkon achieved inactivation of the coronavirus strain at a 1:100 dilution rate with a 10-minute contact time. This corresponds to test conditions required by the U.S. Environmental Protection Agency (EPA) and proves the performance and suitability of Rely+On Virkon for practical use.
Rely+On Virkon is diluted for application and sprayed on hard surfaces and equipment. It can therefore help to reduce the risk of contamination of surfaces, door handles, tables or chairs during disinfection measures at public transport terminals, airports, hospitals, clinics, shopping malls, etc.
EASY TO PREPARE
Readily soluble in tap water, Rely+On" Virkon" dissolves into a yellow solution, which remains stable for up to 7 days, as a 1:100 solution.*
Contact Time: Allow surface to remain wet for 10 minutes.
* Please consult the Rely+On" Virkon" product container label for a comprehensive list of organisms & directions for use.
MODE OF ACTION
Rely+On" Virkon" oxidizes key structures and compounds, such as proteins, leading to widespread, irreversible damage and subsequent deactivation/ destruction of the microorganism. Based on this mode of action, there is no evidence to suggest that bacterial disease-causing organisms develop resistance towards Rely+On" Virkon" as opposed to some other disinfectant types.
APPLICATIONS
For use in cleaning and disinfecting hard non-porous surfaces in institutional, commercial and public service facilities including hospitals and nursing homes, field medical units, medical and dental offices, clinics and other healthcare facilities, Emergency Medical Services (EMS) facilities, equipment and gear including respirators, laboratories, schools and daycare centers, food processing plants, equipment and warehouses, correctional facilities, and transportation terminals and vehicles including ships, trucks and trains.
CLEANING AND DISINFECTING HARD NON-POROUS FOOD CONTACT SURFACES
- Remove gross dirt and prepare a 1% solution according to the dilution table below.
- Apply to surface using a sponge, brush or spray device until the surface is visibly clean
- Let stand for 10 minutes and rinse with potable water.
- In cases of fungal contamination of non-food contact surfaces, follow these instructions substituting a 2% Rely+On" Virkon" solution.
This product is not to be used on any surface or instrument that (1) is introduced directly into the human body, either into or in contact with the bloodstream or normally sterile areas of the body, or (2) contacts intact mucous membranes but which does not ordinarily penetrate the blood barrier or otherwise enter normally sterile areas of the body.
EFFICACY TABLE
Rely+On" Virkon" Human Health Pathogen/Disease
Hepatitis A Virus (HAV) | Streptococcus pyogenes |
Hepatitis B Virus (HBV) | Helicobacter pylori |
Hepatitis C Virus (HCV) | Klebsiella pneumoniae |
HIV (AIDS virus) | Escherichia coli (O157:H7) |
Influenza A Virus | Salmonella typhimurium |
Respiratory Syncytial Virus (RSV) | Salmonella enterica |
Norovirus (Norwalk-like Viruses) | Pseudomonas aeruginosa |
Avian Influenza Virus | Staphylococcus aureus |
Bacillus cereus | Staphylococcus epidermidis |
Campylobacter jejuni | Methicillin-Resistant Staphylococcus aureus (MRSA) |
Health and Safety Information: Appropriate literature has been assembled which provides information concerning the health and safety precautions that must be observed when handling the LANXESS products mentioned in this publication. For materials mentioned which are not LANXESS products, appropriate industrial hygiene and other safety precautions recommended by their manufacturers should be followed. Before working with any of these products, you must read and become familiar with the available information on their hazards, proper use, and handling. This cannot be overemphasized. Information is available in several forms, e.g., material safety data sheets and product labels. Consult your LANXESS Corporation representative or contact the Product Safety and Regulatory Affairs Department at LANXESS.
5kg pail makes 135 gallons (total sq. ft. disinfectant coverage = 18,225 sq. ft.)
Technical Specifications:
Technical Specifications | EFFICACY TABLE Rely+On" Virkon" Human Health Pathogen/Disease
|
---|
Lanxess Disinfectant Kills Coronavirus SARS-CoV-2 in 60 Seconds.
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.